Tractebel Pantera

Tractebel To Support PanTera’s Radioisotope Production Facility

Tractebel To Support PanTera’s Radioisotope Production Facility Tractebel (ENS Corporate Member), together with its partner MODULO architects, will support the design and construction of PanTera’s actinium-225 production facility in Belgium, enabling breakthrough cancer treatments. The PanTera facility will be built in Mol (Belgium) and is dedicated to the production of 225Ac via photonuclear activation on…

NUWARD

European Commission Approves State Measures Supporting NUWARD Project

European Commission Approves State Measures Supporting NUWARD Project The European Commission has approved, under EU State aid rules, a €300 million French measure to support NUWARD – EDF (ENS Corporate Member) subsidiary – in researching and developing small modular nuclear reactors (SMRs). The measure will contribute to achieving the strategic objectives of the European industrial strategy and…

Considerations on the Resilience and Potential Risks of the Zaporizhzhia NPP Against Drone Attacks

Considerations on the Resilience and Potential Risks of the Zaporizhzhia NPP Against Drone Attacks Prof. Dr. Attila Aszódi Thirty-eight years ago, on 26 April 1986, the Chernobyl nuclear power plant accident, the largest nuclear accident in history, occurred in the then-Soviet Union, now Ukraine. The accident attracted enormous attention and its serious consequences have become…

Sarah Baatout - Nuclear medicine

“Advancing Healthcare” – Exploring the Frontiers of Nuclear Medicine

“Advancing Healthcare” Exploring the Frontiers of Nuclear Medicine In the field of healthcare innovation, nuclear medicine and radiopharmaceuticals stand out for their remarkable contributions to diagnosis and treatment. These technologies offer personalized approaches and targeted therapies, which are revolutionizing patient care. However, to ensure access to these cutting-edge treatments for all, it’s crucial to support…

nuclear medicine cooperation

NRG|PALLAS and Curium Expand Cooperation in Lu-177 Production

NRG|PALLAS and Curium Expand Cooperation in Lu-177 Production NRGIPALLAS (ENS Corporate Member) and Curium have signed a long-term agreement to expand the current cooperation to include the production of lutetium-177 (Lu-177). This agreement will enable Curium to supply about 70,000 doses of Lu-177 annually, which will help about 14,000 patients per year. Curium and NRG…

Belgium

The Vast Majority of Belgians Support Nuclear Energy

The Vast Majority of Belgians Support Nuclear Energy An opinion poll by AQ Rate, commissioned by the Belgian Nuclear Forum, shows that the vast majority of Belgians are in favour of continuing to use nuclear energy, maintaining the operation of existing nuclear reactors for as long as possible while also calling for the construction of…